Arcus Biosciences Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 84.62, 118.17, 192.89, 381.18, 822.3 ], "ebit_estimate": [ -471.18, -464.05, -331.41, -243.1, 222.78 ], "ebitda_estimate": [ -472.08, -454.48, -285.63, null, null ], "net_income_estimate": [ -463.99, -449.69, -415.8, -139.58, 251.5 ], "per_share_eps_estimate": [ -3.77, -3.41, -2.83, -1.5, 0.67 ], "eps_nri_estimate": [ -3.77, -3.5, -3.01, -0.99, 1.52 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 1.51, -1.64, 1.52, null, null ], "pretax_income_estimate": [ -461.75, -461.05, -362.09, -139.58, 261.98 ], "operating_cash_flow_per_share_estimate": [ -3.39, -1.86, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -83.26, -432.38, 31.13, null, null ], "gross_margin_estimate": [ 100, 100, 94, 93, 93 ], "operating_cash_flow_estimate": [ -425.11, -233.24, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 43.23 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -1.84, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 23.32, 19.37, 26.31, 7.52, 9.2, 5.93, 5.78, null ], "ebit_estimate": [ -117.91, -119.48, -112.68, -128.75, -119.5, -119, -118, null ], "ebitda_estimate": [ -120.48, -121.29, -116.46, -142.18, null, null, null, null ], "net_income_estimate": [ -114.31, -116.79, -111.46, -113.1, -112.3, -112.55, -112.3, null ], "per_share_eps_estimate": [ -0.91, -0.93, -0.86, -0.94, -0.92, -0.93, -0.9, null ], "eps_nri_estimate": [ -0.92, -0.93, -0.86, -0.94, -0.92, -0.93, -0.9, -0.95 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -114.98, -116.96, -110.1, -113.1, -112.3, -112.55, -112.3, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ -104.45, -127.5, -123.88, null, null, null, null, null ], "gross_margin_estimate": [ 100, 100, 100, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -1.84, "future_operating_cash_flow_per_share_estimate_growth": null }